DK3444613T3 - Fremgangsmåder til diagnosticering og behandling af autisme - Google Patents
Fremgangsmåder til diagnosticering og behandling af autisme Download PDFInfo
- Publication number
- DK3444613T3 DK3444613T3 DK18199149.8T DK18199149T DK3444613T3 DK 3444613 T3 DK3444613 T3 DK 3444613T3 DK 18199149 T DK18199149 T DK 18199149T DK 3444613 T3 DK3444613 T3 DK 3444613T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosing
- methods
- treating autism
- autism
- treating
- Prior art date
Links
- 206010003805 Autism Diseases 0.000 title 1
- 208000020706 Autistic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23411009P | 2009-08-14 | 2009-08-14 | |
| EP10749543.4A EP2464976B1 (en) | 2009-08-14 | 2010-08-12 | Methods of diagnosing and treating autism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3444613T3 true DK3444613T3 (da) | 2021-06-21 |
Family
ID=43101657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10749543.4T DK2464976T3 (da) | 2009-08-14 | 2010-08-12 | Fremgangsmåder til diagnosticering og behandling af autisme |
| DK18199149.8T DK3444613T3 (da) | 2009-08-14 | 2010-08-12 | Fremgangsmåder til diagnosticering og behandling af autisme |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10749543.4T DK2464976T3 (da) | 2009-08-14 | 2010-08-12 | Fremgangsmåder til diagnosticering og behandling af autisme |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8383360B2 (da) |
| EP (2) | EP2464976B1 (da) |
| JP (2) | JP5823964B2 (da) |
| CN (2) | CN105911275B (da) |
| CA (1) | CA2771102C (da) |
| DK (2) | DK2464976T3 (da) |
| ES (1) | ES2875764T3 (da) |
| MX (2) | MX2012001746A (da) |
| WO (1) | WO2011019929A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105911275B (zh) | 2009-08-14 | 2018-06-29 | 加利福尼亚大学董事会 | 诊断自闭症的试剂盒 |
| US10039777B2 (en) | 2012-03-20 | 2018-08-07 | Neuro-Lm Sas | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| CN102831856B (zh) * | 2012-07-17 | 2016-04-13 | 联想(北京)有限公司 | 一种控制方法及电子设备 |
| JP2014113108A (ja) * | 2012-12-11 | 2014-06-26 | Tokyo Medical Univ | タンパク質の可溶化活性を有する多量体タンパク質およびその用途 |
| US9176113B1 (en) * | 2014-04-11 | 2015-11-03 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
| US20150294081A1 (en) | 2014-04-11 | 2015-10-15 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
| CN108184330B (zh) * | 2015-06-26 | 2021-08-06 | 加利福尼亚大学董事会 | 抗原肽及其用于诊断和治疗自闭症的用途 |
| EP3359186B1 (en) | 2015-10-05 | 2021-06-02 | The Feinstein Institute for Medical Research | Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies |
| CN105652016A (zh) * | 2016-01-28 | 2016-06-08 | 深圳大学 | 一种孤独症检测标志物及其检测方法 |
| JP6830578B2 (ja) * | 2016-09-01 | 2021-02-17 | 国立大学法人筑波技術大学 | 自閉症スペクトラム障害の判定方法、自閉症スペクトラム障害の判定用キットおよび測定データ取得方法 |
| CN107058561A (zh) * | 2017-05-04 | 2017-08-18 | 深圳市英马诺生物科技有限公司 | 自闭症生物标志物及其应用 |
| BR112020010430A2 (pt) * | 2017-12-29 | 2020-11-24 | Abbott Laboratories | biomarcadores e métodos inovadores para diagnosticar e avaliar lesão cerebral traumática |
| CN109813912B (zh) * | 2019-01-04 | 2021-12-28 | 深圳大学 | 一组血清差异蛋白组合在制备用于检测孤独症的试剂中的应用 |
| CA3160106A1 (en) * | 2019-11-25 | 2021-06-03 | The Regents Of The University Of California | Antigenic neuron specific enolase peptides for diagnosing and treating autism |
| CN113238045B (zh) * | 2021-04-27 | 2021-12-28 | 南方医科大学南方医院 | Crmp2及抗crmp2抗体的应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
| IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
| US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
| US5519134A (en) | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
| US5593853A (en) | 1994-02-09 | 1997-01-14 | Martek Corporation | Generation and screening of synthetic drug libraries |
| US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
| US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
| US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
| US5569588A (en) | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
| CN1123771C (zh) * | 1996-06-11 | 2003-10-08 | 财团法人工业技术研究院 | 一种急性心肌梗塞检测试剂盒 |
| EP0941474B1 (en) | 1996-11-29 | 2006-03-29 | The Board Of Trustees Of The Leland Stanford Junior University | Arrays of independently-addressable supported fluid bilayer membranes and methods of use thereof |
| US7030098B2 (en) | 1999-03-12 | 2006-04-18 | The Board Of Trustees Of The Leland Stanford Junior University | DNA vaccination for treatment of autoimmune disease |
| CN1313342A (zh) * | 2001-02-28 | 2001-09-19 | 南京医科大学 | 人睾丸新型乳酸脱氢酶a基因编码蛋白 |
| AU2002305861A1 (en) * | 2001-06-08 | 2002-12-23 | Incyte Genomics Inc. | Intracellular signaling molecules |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| CA2435758C (en) | 2001-11-21 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Polynucleotide therapy against autoantigens for treating insulin dependent diabetes mellitus |
| EP1583504A4 (en) | 2002-12-26 | 2008-03-05 | Cemines Llc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER |
| US7452678B2 (en) * | 2003-06-24 | 2008-11-18 | Bristol-Myers Squibb Company | Identification of biomarkers for liver toxicity |
| WO2005007090A2 (en) | 2003-07-03 | 2005-01-27 | President And Fellows Of Harvard College | Inhibitors of the map kinase pathway |
| WO2005081714A2 (en) | 2003-11-21 | 2005-09-09 | Revivicor, Inc. | Use of interfering rna in the production of transgenic animals |
| CA2598889A1 (en) | 2005-02-24 | 2006-08-31 | Cemines, Inc. | Compositions and methods for classifying biological samples |
| WO2006121912A2 (en) * | 2005-05-05 | 2006-11-16 | The Regents Of The University Of California | Diagnostic methods for the detection of risk of neurodevelopmental disorders |
| US7604948B2 (en) * | 2005-05-05 | 2009-10-20 | The Regents Of The University Of California | Biomarkers for diagnosing an autism spectrum disorder |
| GB0524609D0 (en) | 2005-12-02 | 2006-01-11 | Univ Cambridge Tech | Methods of monitoring and diagnosing psychotic disorders and of identifying biomarkers for psychotic disorders |
| GB0602992D0 (en) * | 2006-02-15 | 2006-03-29 | Morvus Technology Ltd | Methods, genes and proteins |
| WO2008070311A2 (en) * | 2006-10-20 | 2008-06-12 | Gene Logic, Inc. | Gene expression profiling of parkinson's disease |
| US8518651B2 (en) | 2007-02-16 | 2013-08-27 | Shimadzu Corporation | Marker for identification of tissue type of epithelial ovarian cancer, and method for determination of the occurrence of epithelial ovarian cancer based on tissue type by using the marker |
| WO2008118350A1 (en) | 2007-03-23 | 2008-10-02 | Advpharma, Inc. | Compositions and methods of using crmp-1 and its fragments for treating cancer |
| WO2009075883A2 (en) | 2007-12-12 | 2009-06-18 | University Of Georgia Research Foundation, Inc. | Glycoprotein cancer biomarker |
| CN105911275B (zh) | 2009-08-14 | 2018-06-29 | 加利福尼亚大学董事会 | 诊断自闭症的试剂盒 |
| JO3421B1 (ar) | 2011-06-20 | 2019-10-20 | H Lundbeck As | طريقة لإعطاء 1-((1ار.3س)-6-كلورو-3-فينيل-اندان-1-ايل)-1.2.2-ترايميثيل- بيبيرازين واملاجها لمعالجة انفصام الشخصية |
| US20140134187A1 (en) | 2012-06-25 | 2014-05-15 | The Johns Hopkins University | Therapeutic and diagnostic methods for autism spectrum disorders and other conditions |
| CN108184330B (zh) | 2015-06-26 | 2021-08-06 | 加利福尼亚大学董事会 | 抗原肽及其用于诊断和治疗自闭症的用途 |
-
2010
- 2010-08-12 CN CN201610335025.6A patent/CN105911275B/zh active Active
- 2010-08-12 EP EP10749543.4A patent/EP2464976B1/en active Active
- 2010-08-12 US US12/855,558 patent/US8383360B2/en active Active
- 2010-08-12 CN CN201080044590.8A patent/CN102576022B/zh active Active
- 2010-08-12 CA CA2771102A patent/CA2771102C/en active Active
- 2010-08-12 EP EP18199149.8A patent/EP3444613B1/en active Active
- 2010-08-12 ES ES18199149T patent/ES2875764T3/es active Active
- 2010-08-12 JP JP2012524877A patent/JP5823964B2/ja active Active
- 2010-08-12 DK DK10749543.4T patent/DK2464976T3/da active
- 2010-08-12 WO PCT/US2010/045343 patent/WO2011019929A1/en active Application Filing
- 2010-08-12 DK DK18199149.8T patent/DK3444613T3/da active
- 2010-08-12 MX MX2012001746A patent/MX2012001746A/es active IP Right Grant
-
2012
- 2012-02-09 MX MX2019014978A patent/MX2019014978A/es unknown
-
2013
- 2013-01-30 US US13/754,846 patent/US9529001B2/en active Active
-
2015
- 2015-06-24 JP JP2015126311A patent/JP6105678B2/ja active Active
-
2016
- 2016-11-16 US US15/353,037 patent/US10520499B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5823964B2 (ja) | 2015-11-25 |
| US10520499B2 (en) | 2019-12-31 |
| MX2019014978A (es) | 2020-02-24 |
| EP3444613A1 (en) | 2019-02-20 |
| ES2875764T3 (es) | 2021-11-11 |
| MX2012001746A (es) | 2012-03-21 |
| CN102576022A (zh) | 2012-07-11 |
| US20110038872A1 (en) | 2011-02-17 |
| CA2771102A1 (en) | 2011-02-17 |
| US20130210037A1 (en) | 2013-08-15 |
| US8383360B2 (en) | 2013-02-26 |
| CA2771102C (en) | 2019-10-15 |
| EP2464976B1 (en) | 2018-11-21 |
| JP6105678B2 (ja) | 2017-03-29 |
| JP2013501942A (ja) | 2013-01-17 |
| CN105911275A (zh) | 2016-08-31 |
| JP2015180897A (ja) | 2015-10-15 |
| US9529001B2 (en) | 2016-12-27 |
| US20170191994A1 (en) | 2017-07-06 |
| EP3444613B1 (en) | 2021-05-19 |
| CN105911275B (zh) | 2018-06-29 |
| DK2464976T3 (da) | 2019-03-04 |
| CN102576022B (zh) | 2016-06-15 |
| WO2011019929A1 (en) | 2011-02-17 |
| EP2464976A1 (en) | 2012-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3444613T3 (da) | Fremgangsmåder til diagnosticering og behandling af autisme | |
| DK2446090T3 (da) | Indretning og fremgangsmåde til reducering af støj | |
| BR112012011910A2 (pt) | dispositivo e método | |
| BRPI1013317A2 (pt) | método de cimentação | |
| BR112012004707A2 (pt) | método | |
| BR112012000624A2 (pt) | método | |
| BRPI0912934A2 (pt) | aparelho e método | |
| FI20090389A0 (fi) | Menetelmä | |
| BRPI0919116A2 (pt) | método | |
| DK2702767T3 (da) | Apparater og fremgangsmåder til hdr-billedkodning og -afkodning | |
| DK2457153T3 (da) | Metode og system til effektanalyse | |
| DK2482460T3 (da) | Låsesystem og fremgangsmåde deraf | |
| BRPI0910713A2 (pt) | método e aparelhos | |
| DK3128014T3 (da) | Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger | |
| BRPI0910854A2 (pt) | métodos de tratamento | |
| DK2321661T3 (da) | Fremgangsmåde og system til deludladningsovervågning | |
| BR112012015031A2 (pt) | aparelho e método | |
| BRPI1012526A2 (pt) | método | |
| DK2398902T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af cancer | |
| DK2313489T3 (da) | Fremstillingsmetode | |
| DK2446246T3 (da) | Indretning og fremgangsmåde til udvælgelse af partikler | |
| DK2309938T3 (da) | Kryokirurgiske systemer og fremgangsmåder til anvendelse heraf | |
| BRPI1010705A2 (pt) | método | |
| DK2222314T3 (da) | Anvendelser og midler til opnåelse af bronchorelaxation | |
| BR112012008229A2 (pt) | método, e aparelho |